3-D Matrix, Ltd. (TYO:7777)
Japan
· Delayed Price · Currency is JPY 197.00
+4.00 (2.07%)
Jul 11, 2025, 3:30 PM JST
3-D Matrix Revenue
In the fiscal year ending April 30, 2025, 3-D Matrix had annual revenue of 6.93B JPY with 51.13% growth. 3-D Matrix had revenue of 1.88B in the quarter ending April 30, 2025, with 16.90% growth.
Revenue
6.93B
Revenue Growth
+51.13%
P/S Ratio
3.13
Revenue / Employee
65.42M
Employees
106
Market Cap
21.73B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2025 | 6.93B | 2.35B | 51.13% |
| Apr 30, 2024 | 4.59B | 2.27B | 98.27% |
| Apr 30, 2023 | 2.31B | 808.00M | 53.65% |
| Apr 30, 2022 | 1.51B | 482.00M | 47.07% |
| Apr 30, 2021 | 1.02B | 352.00M | 52.38% |
| Apr 30, 2020 | Pro | Pro | Pro |
| Apr 30, 2019 | Pro | Pro | Pro |
| Apr 30, 2018 | Pro | Pro | Pro |
| Apr 30, 2017 | Pro | Pro | Pro |
| Apr 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| HOYA Corporation | 866.03B |
| Daiichi Sankyo Company | 1,886.26B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Shionogi & | 438.27B |